Ocean Accounts Payable vs Net Tangible Assets Analysis
| OCEA Stock | 0.71 0.02 3.32% |
Ocean Biomedical financial indicator trend analysis is much more than just breaking down Ocean Biomedical prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ocean Biomedical is a good investment. Please check the relationship between Ocean Biomedical Accounts Payable and its Net Tangible Assets accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocean Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.
Accounts Payable vs Net Tangible Assets
Accounts Payable vs Net Tangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ocean Biomedical Accounts Payable account and Net Tangible Assets. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Ocean Biomedical's Accounts Payable and Net Tangible Assets is -0.19. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of Ocean Biomedical, assuming nothing else is changed. The correlation between historical values of Ocean Biomedical's Accounts Payable and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Ocean Biomedical are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Accounts Payable i.e., Ocean Biomedical's Accounts Payable and Net Tangible Assets go up and down completely randomly.
Correlation Coefficient | -0.19 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Accounts Payable
An accounting item on the balance sheet that represents Ocean Biomedical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Ocean Biomedical are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Most indicators from Ocean Biomedical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ocean Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocean Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.The current year's Selling General Administrative is expected to grow to about 34.3 M, whereas Issuance Of Capital Stock is forecasted to decline to 0.00.
| 2010 | 2023 | 2024 (projected) | Net Interest Income | 1.5M | 1.4M | 1.2M | Interest Expense | 1K | 621.9 | 676.4 |
Ocean Biomedical fundamental ratios Correlations
Click cells to compare fundamentals
Ocean Biomedical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ocean Biomedical is a strong investment it is important to analyze Ocean Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ocean Biomedical's future performance. For an informed investment choice regarding Ocean Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocean Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocean Biomedical. If investors know Ocean will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocean Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.00) | Return On Assets (6.82) |
The market value of Ocean Biomedical is measured differently than its book value, which is the value of Ocean that is recorded on the company's balance sheet. Investors also form their own opinion of Ocean Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Ocean Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocean Biomedical's market value can be influenced by many factors that don't directly affect Ocean Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocean Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocean Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocean Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.